TermID Term Enrichment logP Genes in Term Target Genes in Term Fraction of Targets in Term Total Target Genes Total Genes Entrez Gene IDs Gene Symbols WP3679 Cell-type Dependent Selectivity of CCK2R Signaling 0.00124343944490234 -6.68987399321068 13 2 0.0909090909090909 22 5310 6263,23236 RYR3,PLCB1 WP2447 Amyotrophic lateral sclerosis (ALS) 0.0105266409836886 -4.55384599862732 38 2 0.0909090909090909 22 5310 6506,1471 SLC1A2,CST3 WP673 ErbB Signaling Pathway 0.0205889905956856 -3.88299878315166 54 2 0.0909090909090909 22 5310 10718,2066 NRG3,ERBB4 WP2059 Alzheimers Disease 0.0221598805251853 -3.80947180858034 148 3 0.136363636363636 22 5310 348,23236,6263 APOE,PLCB1,RYR3 WP536 Calcium Regulation in the Cardiac Cell 0.0233565817424346 -3.75687646124838 151 3 0.136363636363636 22 5310 108,6263,818 ADCY2,RYR3,CAMK2G WP289 Myometrial Relaxation and Contraction Pathways 0.0262855445000332 -3.63873612968719 158 3 0.136363636363636 22 5310 108,6263,818 ADCY2,RYR3,CAMK2G WP2032 Human Thyroid Stimulating Hormone (TSH) signaling pathway 0.0316534589837578 -3.45290784777717 68 2 0.0909090909090909 22 5310 23236,108 PLCB1,ADCY2 WP3297 EV release from cardiac cells and their functional effects 0.036703314875436 -3.30488820441918 9 1 0.0454545454545455 22 5310 2066 ERBB4 WP3601 Composition of Lipid Particles 0.0407011505805599 -3.20149891714054 10 1 0.0454545454545455 22 5310 348 APOE WP3301 MFAP5-mediated ovarian cancer cell motility and invasiveness 0.0486493603345804 -3.0231166187494 12 1 0.0454545454545455 22 5310 6263 RYR3 WP3594 Circadian rythm related genes 0.0521070778115076 -2.95445448894088 207 3 0.136363636363636 22 5310 1471,6095,5602 CST3,RORA,MAPK10 WP3853 ERK Pathway in Huntington's Disease 0.0565346853859066 -2.87290092855414 14 1 0.0454545454545455 22 5310 4915 NTRK2 WP2064 Neural Crest Differentiation 0.0657954563122934 -2.72120449603979 102 2 0.0909090909090909 22 5310 6660,2670 SOX5,GFAP WP185 Integrin-mediated Cell Adhesion 0.0669329942400179 -2.7040632459807 103 2 0.0909090909090909 22 5310 5602,10580 MAPK10,SORBS1 WP3678 Amplification and Expansion of Oncogenic Pathways as Metastatic Traits 0.0682458001327838 -2.68463938332651 17 1 0.0454545454545455 22 5310 3371 TNC WP3859 TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition 0.0721185740596712 -2.62944365261632 18 1 0.0454545454545455 22 5310 3371 TNC WP384 Apoptosis Modulation by HSP70 0.0759759798356985 -2.57733804344509 19 1 0.0454545454545455 22 5310 5602 MAPK10 WP1602 Nicotine Activity on Dopaminergic Neurons 0.0836449190967248 -2.48117459342125 21 1 0.0454545454545455 22 5310 108 ADCY2 WP26 Signal Transduction of S1P Receptor 0.102552365559712 -2.27738172735084 26 1 0.0454545454545455 22 5310 23236 PLCB1 WP2643 Nanoparticle-mediated activation of receptor signaling 0.113717466773445 -2.174038268446 29 1 0.0454545454545455 22 5310 5602 MAPK10 WP422 MAPK Cascade 0.113717466773445 -2.174038268446 29 1 0.0454545454545455 22 5310 5602 MAPK10 WP2858 Ectoderm Differentiation 0.117261863433369 -2.14334569610577 143 2 0.0909090909090909 22 5310 1501,1496 CTNND2,CTNNA2 WP2380 Brain-Derived Neurotrophic Factor (BDNF) signaling pathway 0.118623032741317 -2.13180460603515 144 2 0.0909090909090909 22 5310 5602,4915 MAPK10,NTRK2 WP408 Oxidative Stress 0.121087071345261 -2.1112453942771 31 1 0.0454545454545455 22 5310 5602 MAPK10 WP3893 Development and heterogeneity of the ILC family 0.124749902265553 -2.08144432779328 32 1 0.0454545454545455 22 5310 6095 RORA WP430 Statin Pathway 0.128398159588095 -2.05261922125505 33 1 0.0454545454545455 22 5310 348 APOE WP2197 Endothelin Pathways 0.128398159588095 -2.05261922125505 33 1 0.0454545454545455 22 5310 23236 PLCB1 WP3676 BDNF-TrkB Signaling 0.128398159588095 -2.05261922125505 33 1 0.0454545454545455 22 5310 4915 NTRK2 WP3298 Melatonin metabolism and effects 0.139256041320027 -1.97144101641187 36 1 0.0454545454545455 22 5310 348 APOE WP481 Insulin Signaling 0.142364278826866 -1.94936616240755 161 2 0.0909090909090909 22 5310 10580,5602 SORBS1,MAPK10 WP706 Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways 0.14379326729535 -1.93937865471235 162 2 0.0909090909090909 22 5310 4915,6095 NTRK2,RORA WP170 Nuclear Receptors 0.149984737213251 -1.89722174197462 39 1 0.0454545454545455 22 5310 6095 RORA WP524 G13 Signaling Pathway 0.153532514822076 -1.87384291144108 40 1 0.0454545454545455 22 5310 5602 MAPK10 WP2637 Structural Pathway of Interleukin 1 (IL-1) 0.188241532602947 -1.67002939284656 50 1 0.0454545454545455 22 5310 5602 MAPK10 WP2267 Synaptic Vesicle Pathway 0.195018350105561 -1.63466162174037 52 1 0.0454545454545455 22 5310 477 ATP1A2 WP1533 Vitamin B12 Metabolism 0.198386474166036 -1.61753826102171 53 1 0.0454545454545455 22 5310 348 APOE WP2864 Apoptosis-related network due to altered Notch3 in ovarian cancer 0.201741143666724 -1.60076987035831 54 1 0.0454545454545455 22 5310 348 APOE WP2795 Cardiac Hypertrophic Response 0.211724935872774 -1.55246731905432 57 1 0.0454545454545455 22 5310 5592 PRKG1 WP558 Complement and Coagulation Cascades 0.221589469088932 -1.50692884740008 60 1 0.0454545454545455 22 5310 1191 CLU WP3865 RIG-I-like Receptor Signaling 0.224851379886216 -1.49231562886535 61 1 0.0454545454545455 22 5310 5602 MAPK10 WP474 Endochondral Ossification 0.237769018218028 -1.43645558825102 65 1 0.0454545454545455 22 5310 6660 SOX5 WP3680 Association Between Physico-Chemical Features and Toxicity Associated Pathways 0.247322124366665 -1.39706364478206 68 1 0.0454545454545455 22 5310 2066 ERBB4 WP1403 AMP-activated Protein Kinase (AMPK) Signaling 0.247322124366665 -1.39706364478206 68 1 0.0454545454545455 22 5310 23236 PLCB1 WP428 Wnt Signaling Pathway 0.253627251629188 -1.37188960308675 70 1 0.0454545454545455 22 5310 5602 MAPK10 WP2118 Arrhythmogenic Right Ventricular Cardiomyopathy 0.272241552159052 -1.30106554736932 76 1 0.0454545454545455 22 5310 1496 CTNNA2 WP254 Apoptosis 0.302284513389388 -1.19638660778657 86 1 0.0454545454545455 22 5310 5602 MAPK10 WP35 G Protein Signaling Pathways 0.328307795256529 -1.11380371044783 95 1 0.0454545454545455 22 5310 108 ADCY2 WP1544 MicroRNAs in cardiomyocyte hypertrophy 0.34790486232225 -1.05582622071538 102 1 0.0454545454545455 22 5310 5592 PRKG1 WP75 Toll-like Receptor Signaling Pathway 0.350659488480152 -1.04793964467574 103 1 0.0454545454545455 22 5310 5602 MAPK10 WP399 Wnt Signaling Pathway and Pluripotency 0.358856880533909 -1.0248316314459 106 1 0.0454545454545455 22 5310 5602 MAPK10 WP710 DNA Damage Response (only ATM dependent) 0.380236462244726 -0.966961950725752 114 1 0.0454545454545455 22 5310 5602 MAPK10 WP2431 Spinal Cord Injury 0.393251270092914 -0.933306507314918 119 1 0.0454545454545455 22 5310 2670 GFAP WP236 Adipogenesis 0.423430879331842 -0.85936499112253 131 1 0.0454545454545455 22 5310 6095 RORA WP3915 Angiopoietin Like Protein 8 Regulatory Pathway 0.425880101316332 -0.853597424636981 132 1 0.0454545454545455 22 5310 5602 MAPK10 WP366 TGF-beta Signaling Pathway 0.428319390186832 -0.847886122943756 133 1 0.0454545454545455 22 5310 3371 TNC WP1449 Regulation of toll-like receptor signaling pathway 0.456829901893402 -0.783444163296284 145 1 0.0454545454545455 22 5310 5602 MAPK10 WP2857 Mesodermal Commitment Pathway 0.479546860423297 -0.734913661752146 155 1 0.0454545454545455 22 5310 23499 MACF1 WP382 MAPK Signaling Pathway 0.511929490524398 -0.669568377245584 170 1 0.0454545454545455 22 5310 5602 MAPK10 WP306 Focal Adhesion 0.561668861548196 -0.576842817070478 195 1 0.0454545454545455 22 5310 3371 TNC WP2377 Integrated Pancreatic Cancer Pathway 0.565431710254678 -0.570165750656708 197 1 0.0454545454545455 22 5310 1471 CST3 WP195 IL-1 signaling pathway 0.999999999989775 -1.02245958177373e-11 57 0 0 22 5310 WP3876 BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP3871 Valproic acid pathway 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP1991 SRF and miRs in Smooth Muscle Differentiation and Proliferation 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP3892 Development of pulmonary dendritic cells and macrophage subsets 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP2881 Estrogen Receptor Pathway 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP186 Homologous recombination 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP1423 Ganglio Sphingolipid Metabolism 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP1434 Osteopontin Signaling 0.999999999991404 -8.59646208349465e-12 13 0 0 22 5310 WP383 Striated Muscle Contraction 0.999999999991613 -8.38671277349956e-12 38 0 0 22 5310 WP2029 Cell Differentiation - Index 0.999999999991613 -8.38671277349956e-12 38 0 0 22 5310 WP2526 PDGF Pathway 0.999999999991613 -8.38671277349956e-12 38 0 0 22 5310 WP3407 FTO Obesity Variant Mechanism 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP3635 Insulin signalling in human adipocytes (diabetic condition) 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP237 Glucocorticoid & Mineralcorticoid Metabolism 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP136 Phase I biotransformations, non P450 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP2338 miRNA Biogenesis 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP3655 Hypothetical Craniofacial Development Pathway 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP2276 Glial Cell Differentiation 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP3634 Insulin signalling in human adipocytes (normal condition) 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP2485 NAD Biosynthesis II (from tryptophan) 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP1604 Codeine and Morphine Metabolism 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP1589 Folate-Alcohol and Cancer Pathway 0.999999999991964 -8.03640487181492e-12 8 0 0 22 5310 WP2359 Parkin-Ubiquitin Proteasomal System pathway 0.999999999992225 -7.77546251582742e-12 70 0 0 22 5310 WP2035 Follicle Stimulating Hormone (FSH) signaling pathway 0.999999999992666 -7.3336782395673e-12 27 0 0 22 5310 WP3845 Canonical and Non-canonical Notch signaling 0.999999999992666 -7.3336782395673e-12 27 0 0 22 5310 WP585 Interferon type I signaling pathways 0.999999999993481 -6.51875441132941e-12 55 0 0 22 5310 WP2272 Pathogenic Escherichia coli infection 0.999999999993481 -6.51875441132941e-12 55 0 0 22 5310 WP2018 RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway 0.999999999993481 -6.51875441132941e-12 55 0 0 22 5310 WP395 IL-4 Signaling Pathway 0.999999999993481 -6.51875441132941e-12 55 0 0 22 5310 WP2324 AGE/RAGE pathway 0.999999999994106 -5.89387473060292e-12 66 0 0 22 5310 WP3651 Pathways Affected in Adenoid Cystic Carcinoma 0.999999999994106 -5.89387473060292e-12 66 0 0 22 5310 WP2374 Oncostatin M Signaling Pathway 0.999999999994106 -5.89387473060292e-12 66 0 0 22 5310 WP183 Proteasome Degradation 0.999999999994106 -5.89387473060292e-12 66 0 0 22 5310 WP3877 Simplified Depiction of MYD88 Distinct Input-Output Pathway 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP3287 Overview of nanoparticle effects 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP1992 TarBasePathway 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP2879 Farnesoid X Receptor Pathway 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP734 Serotonin Receptor 4/6/7 and NR3C Signaling 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP404 Nucleotide Metabolism 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP247 Small Ligand GPCRs 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP22 IL-9 Signaling Pathway 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP697 Estrogen metabolism 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP2011 SREBF and miR33 in cholesterol and lipid homeostasis 0.999999999994122 -5.87820180328606e-12 19 0 0 22 5310 WP3408 Evolocumab Mechanism 0.999999999994245 -5.75518918743408e-12 3 0 0 22 5310 WP2846 Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation 0.999999999994245 -5.75518918743408e-12 3 0 0 22 5310 WP531 Mismatch repair 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP3593 miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP3875 ATR Signaling 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP288 NLR Proteins 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP696 Benzo(a)pyrene metabolism 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP3674 Tgif disruption of Shh signaling 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP2942 DDX1 as a regulatory component of the Drosha microprocessor 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP561 Heme Biosynthesis 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP3300 Dual hijack model of Vif in HIV infection 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP3585 Cytosine methylation 0.99999999999446 -5.5401088471315e-12 9 0 0 22 5310 WP500 Glycogen Metabolism 0.999999999995539 -4.46066071430324e-12 36 0 0 22 5310 WP2012 miRs in Muscle Cell Differentiation 0.999999999995539 -4.46066071430324e-12 36 0 0 22 5310 WP176 Folate Metabolism 0.999999999996063 -3.93704748924487e-12 69 0 0 22 5310 WP707 DNA Damage Response 0.999999999996063 -3.93704748924487e-12 69 0 0 22 5310 WP2369 Histone Modifications 0.999999999996063 -3.93704748924487e-12 69 0 0 22 5310 WP262 EBV LMP1 signaling 0.999999999996351 -3.64939849990963e-12 24 0 0 22 5310 WP3658 Wnt/beta-catenin Signaling Pathway in Leukemia 0.999999999996351 -3.64939849990963e-12 24 0 0 22 5310 WP1539 Angiogenesis 0.999999999996351 -3.64939849990963e-12 24 0 0 22 5310 WP334 GPCRs, Class B Secretin-like 0.999999999996351 -3.64939849990963e-12 24 0 0 22 5310 WP2509 Nanoparticle triggered autophagic cell death 0.999999999996351 -3.64939849990963e-12 24 0 0 22 5310 WP3624 Lung fibrosis 0.999999999997792 -2.2081702129064e-12 63 0 0 22 5310 WP43 Oxidation by Cytochrome P450 0.999999999997792 -2.2081702129064e-12 63 0 0 22 5310 WP2332 Interleukin-11 Signaling Pathway 0.999999999998026 -1.97385966203551e-12 44 0 0 22 5310 WP314 Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation 0.999999999998026 -1.97385966203551e-12 44 0 0 22 5310 WP716 Vitamin A and Carotenoid Metabolism 0.999999999998026 -1.97385966203551e-12 44 0 0 22 5310 WP1531 Vitamin D Metabolism 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP2333 Trans-sulfuration pathway 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP3656 Interleukin-1 Induced Activation of NF-kappa-B 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP704 Methylation Pathways 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP2874 Liver X Receptor Pathway 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP2113 Type III interferon signaling 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP496 Steroid Biosynthesis 0.999999999998063 -1.9369741126967e-12 10 0 0 22 5310 WP391 Mitochondrial Gene Expression 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP497 Urea cycle and metabolism of amino groups 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP732 Serotonin Receptor 2 and ELK-SRF/GATA4 signaling 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP516 Hypertrophy Model 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP1742 TP53 Network 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP1422 Sphingolipid Metabolism 0.999999999998084 -1.91627423369267e-12 20 0 0 22 5310 WP69 T-Cell antigen Receptor (TCR) Signaling Pathway 0.999999999998292 -1.70797619037871e-12 91 0 0 22 5310 WP3925 Amino Acid metabolism 0.999999999998292 -1.70797619037871e-12 91 0 0 22 5310 WP138 Androgen receptor signaling pathway 0.999999999998351 -1.64906450548664e-12 90 0 0 22 5310 WP477 Cytoplasmic Ribosomal Proteins 0.999999999998351 -1.64906450548664e-12 90 0 0 22 5310 WP3613 Photodynamic therapy-induced unfolded protein response 0.999999999998408 -1.59158959380189e-12 29 0 0 22 5310 WP2583 T-Cell Receptor and Co-stimulatory Signaling 0.999999999998408 -1.59158959380189e-12 29 0 0 22 5310 WP2878 PPAR Alpha Pathway 0.999999999998737 -1.26257111152126e-12 26 0 0 22 5310 WP698 Glucuronidation 0.999999999998737 -1.26257111152126e-12 26 0 0 22 5310 WP530 Cytokines and Inflammatory Response 0.999999999998737 -1.26257111152126e-12 26 0 0 22 5310 WP325 Triacylglyceride Synthesis 0.999999999998737 -1.26257111152126e-12 26 0 0 22 5310 WP581 EPO Receptor Signaling 0.999999999998737 -1.26257111152126e-12 26 0 0 22 5310 WP2406 Cardiac Progenitor Differentiation 0.999999999998878 -1.12198707862791e-12 53 0 0 22 5310 WP107 Translation Factors 0.999999999998878 -1.12198707862791e-12 53 0 0 22 5310 WP363 Wnt Signaling Pathway Netpath 0.999999999998878 -1.12198707862791e-12 53 0 0 22 5310 WP2516 ATM Signaling Pathway 0.999999999999137 -8.62502670837309e-13 40 0 0 22 5310 WP127 IL-5 Signaling Pathway 0.999999999999137 -8.62502670837309e-13 40 0 0 22 5310 WP1971 Integrated Cancer Pathway 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP28 Selenium Metabolism and Selenoproteins 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP3878 ATM Signaling Network in Development and Disease 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP465 Tryptophan metabolism 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP268 Notch Signaling Pathway 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP1591 Heart Development 0.999999999999627 -3.7262866929756e-13 46 0 0 22 5310 WP400 p38 MAPK Signaling Pathway 0.99999999999998 -1.95425339028021e-14 34 0 0 22 5310 WP1601 Fluoropyrimidine Activity 0.99999999999998 -1.95425339028021e-14 34 0 0 22 5310 WP143 Fatty Acid Beta Oxidation 0.99999999999998 -1.95425339028021e-14 34 0 0 22 5310 WP313 Signaling of Hepatocyte Growth Factor Receptor 0.99999999999998 -1.95425339028021e-14 34 0 0 22 5310 WP108 Selenium metabolism/Selenoproteins 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP3627 Gut-Liver Indole Metabolism 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP188 Focal Adhesion 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP3191 TSLP Signaling Pathway 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP2190 One carbon donor 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP1 Statin Pathway 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP661 Glucose Homeostasis 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP2536 Colchicine Metabolic Pathway 1.00000000000001 5.10268910458578e-15 1 0 0 22 5310 WP560 TGF-beta Receptor Signaling 1.00000000000028 2.8192598683841e-13 58 0 0 22 5310 WP2328 Allograft Rejection 1.00000000000037 3.71083675295943e-13 80 0 0 22 5310 WP554 ACE Inhibitor Pathway 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP78 TCA Cycle 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP3874 Canonical and Non-Canonical TGF-B signaling 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP2289 Drug Induction of Bile Acid Pathway 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP2916 Interactome of polycomb repressive complex 2 (PRC2) 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP368 Mitochondrial LC-Fatty Acid Beta-Oxidation 1.00000000000043 4.33612476897686e-13 17 0 0 22 5310 WP1545 miRNAs involved in DNA damage response 1.00000000000074 7.43221041621608e-13 50 0 0 22 5310 WP2361 Gastric Cancer Network 1 1.00000000000108 1.08058357552876e-12 28 0 0 22 5310 WP2249 Metastatic brain tumor 1.00000000000108 1.08058357552876e-12 28 0 0 22 5310 WP34 Ovarian Infertility Genes 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP2525 Trans-sulfuration and one carbon metabolism 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP2828 Bladder Cancer 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP2875 Constitutive Androstane Receptor Pathway 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP727 Monoamine Transport 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP3858 Toll-like Receptor Signaling 1.00000000000109 1.09316837142535e-12 32 0 0 22 5310 WP2036 TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway 1.00000000000111 1.1093380162105e-12 42 0 0 22 5310 WP2636 Common Pathways Underlying Drug Addiction 1.00000000000111 1.1093380162105e-12 42 0 0 22 5310 WP466 DNA Replication 1.00000000000111 1.1093380162105e-12 42 0 0 22 5310 WP405 Eukaryotic Transcription Initiation 1.00000000000111 1.1093380162105e-12 42 0 0 22 5310 WP49 IL-2 Signaling Pathway 1.00000000000111 1.1093380162105e-12 42 0 0 22 5310 WP179 Cell Cycle 1.00000000000132 1.32476988327298e-12 105 0 0 22 5310 WP117 GPCRs, Other 1.0000000000014 1.39744623939279e-12 95 0 0 22 5310 WP2884 NRF2 pathway 1.00000000000181 1.80735720961611e-12 143 0 0 22 5310 WP3413 NOTCH1 regulation of human endothelial cell calcification 1.00000000000202 2.02421451088381e-12 18 0 0 22 5310 WP692 Sulfation Biotransformation Reaction 1.00000000000202 2.02421451088381e-12 18 0 0 22 5310 WP3879 4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression 1.00000000000202 2.02421451088381e-12 18 0 0 22 5310 WP3664 Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds 1.00000000000202 2.02421451088381e-12 18 0 0 22 5310 WP2507 Nanomaterial induced apoptosis 1.00000000000225 2.2465955258404e-12 21 0 0 22 5310 WP691 Tamoxifen metabolism 1.00000000000225 2.2465955258404e-12 21 0 0 22 5310 WP3670 Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway 1.00000000000225 2.2465955258404e-12 21 0 0 22 5310 WP2533 Glycerophospholipid Biosynthetic Pathway 1.00000000000225 2.2465955258404e-12 21 0 0 22 5310 WP3 Transcriptional activation by NRF2 1.00000000000235 2.35182314371323e-12 15 0 0 22 5310 WP2435 Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis 1.00000000000235 2.35182314371323e-12 15 0 0 22 5310 WP206 Fatty Acid Omega Oxidation 1.00000000000235 2.35182314371323e-12 15 0 0 22 5310 WP197 Cholesterol Biosynthesis 1.00000000000235 2.35182314371323e-12 15 0 0 22 5310 WP2037 Prolactin Signaling Pathway 1.00000000000244 2.43950574844526e-12 76 0 0 22 5310 WP2034 Leptin signaling pathway 1.00000000000244 2.43950574844526e-12 76 0 0 22 5310 WP3286 Copper homeostasis 1.00000000000312 3.11524483242959e-12 54 0 0 22 5310 WP623 Oxidative phosphorylation 1.00000000000312 3.11524483242959e-12 54 0 0 22 5310 WP1433 Nucleotide-binding Oligomerization Domain (NOD) pathway 1.00000000000317 3.17087725982358e-12 41 0 0 22 5310 WP455 GPCRs, Class A Rhodopsin-like 1.00000000000336 3.35952482974757e-12 259 0 0 22 5310 WP3527 Preimplantation Embryo 1.00000000000342 3.42215093631111e-12 60 0 0 22 5310 WP304 Kit receptor signaling pathway 1.00000000000342 3.42215093631111e-12 60 0 0 22 5310 WP2911 miRNA targets in ECM and membrane receptors 1.00000000000369 3.69177984916822e-12 43 0 0 22 5310 WP364 IL-6 signaling pathway 1.00000000000369 3.69177984916822e-12 43 0 0 22 5310 WP23 B Cell Receptor Signaling Pathway 1.00000000000374 3.74132195777309e-12 98 0 0 22 5310 WP3584 MECP2 and Associated Rett Syndrome 1.00000000000385 3.84670321215652e-12 62 0 0 22 5310 WP61 Notch Signaling Pathway 1.00000000000385 3.84670321215652e-12 62 0 0 22 5310 WP3863 T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection 1.00000000000385 3.84670321215652e-12 62 0 0 22 5310 WP3596 miR-517 relationship with ARCN1 and USP1 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP2597 Secretion of Hydrochloric Acid in Parietal Cells 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP311 Synthesis and Degradation of Ketone Bodies 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP688 Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP2542 Sulindac Metabolic Pathway 1.00000000000392 3.91692793446552e-12 5 0 0 22 5310 WP2203 Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway 1.00000000000402 4.0213624261711e-12 47 0 0 22 5310 WP3872 Regulation of Apoptosis by Parathyroid Hormone-related Protein 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP545 Complement Activation 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP3645 NAD+ biosynthetic pathways 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP3657 Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP272 Blood Clotting Cascade 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP1424 Globo Sphingolipid Metabolism 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP1584 Type II diabetes mellitus 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP357 Fatty Acid Biosynthesis 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP167 Eicosanoid Synthesis 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP100 Glutathione metabolism 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP3599 Transcription factor regulation in adipogenesis 1.00000000000414 4.13888908395668e-12 22 0 0 22 5310 WP3646 Hepatitis C and Hepatocellular Carcinoma 1.00000000000465 4.65280051675028e-12 51 0 0 22 5310 WP3611 Photodynamic therapy-induced AP-1 survival signaling. 1.00000000000465 4.65280051675028e-12 51 0 0 22 5310 WP106 Alanine and aspartate metabolism 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP3849 MAPK and NFkB Signalling Pathways Inhibited by Yersinia YopJ 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP2007 Iron metabolism in placenta 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP1559 TFs Regulate miRNAs related to cardiac hypertrophy 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP1425 Bone Morphogenic Protein (BMP) Signalling and Regulation 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP3672 LncRNA-mediated mechanisms of therapeutic resistance 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP2290 RalA downstream regulated genes 1.00000000000473 4.72763815767633e-12 12 0 0 22 5310 WP2261 Signaling Pathways in Glioblastoma 1.00000000000503 5.02687679601466e-12 83 0 0 22 5310 WP2371 Parkinsons Disease Pathway 1.00000000000503 5.02687679601466e-12 83 0 0 22 5310 WP702 Metapathway biotransformation 1.00000000000505 5.04832166863118e-12 177 0 0 22 5310 WP3633 Caffeine and Theobromine metabolism 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP2253 Pilocytic astrocytoma 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP2491 Diclofenac Metabolic Pathway 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP1603 Nicotine Activity on Chromaffin Cells 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP2889 Oxytocin signaling 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP521 Amino acid conjugation of benzoic acid 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP3302 eIF5A regulation in response to inhibition of the nuclear export system 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP1133 Androgen receptor signaling pathway 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP1941 Peroxisomal beta-oxidation of tetracosanoyl-CoA 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP897 Androgen receptor signaling pathway 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP733 Serotonin Receptor 2 and STAT3 Signaling 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP690 Polyol Pathway 1.00000000000524 5.24181930773357e-12 4 0 0 22 5310 WP3614 Photodynamic therapy-induced HIF-1 survival signaling 1.00000000000533 5.33478731505602e-12 37 0 0 22 5310 WP1471 Target Of Rapamycin (TOR) Signaling 1.00000000000533 5.33478731505602e-12 37 0 0 22 5310 WP619 Type II interferon signaling (IFNG) 1.00000000000533 5.33478731505602e-12 37 0 0 22 5310 WP3529 Zinc homeostasis 1.00000000000533 5.33478731505602e-12 37 0 0 22 5310 WP3414 Initiation of transcription and translation elongation at the HIV-1 LTR 1.00000000000533 5.33478731505602e-12 37 0 0 22 5310 WP411 mRNA Processing 1.00000000000546 5.45997581349432e-12 132 0 0 22 5310 WP3844 PI3K-AKT-mTOR signaling pathway and therapeutic opportunities 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP2870 Extracellular vesicle-mediated signaling in recipient cells 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP3851 TLR4 Signaling and Tolerance 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP241 One Carbon Metabolism 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP2855 Dopaminergic Neurogenesis 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP129 Matrix Metalloproteinases 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP98 Prostaglandin Synthesis and Regulation 1.00000000000565 5.65056084185401e-12 30 0 0 22 5310 WP1982 Sterol Regulatory Element-Binding Proteins (SREBP) signalling 1.00000000000586 5.85945802182484e-12 73 0 0 22 5310 WP678 Arachidonate Epoxygenase / Epoxide Hydrolase 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP3595 mir-124 predicted interactions with cell cycle and differentiation 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP134 Pentose Phosphate Pathway 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP1995 Effects of Nitric Oxide 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP1272 Selenium Micronutrient Network 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP1310 Selenium Micronutrient Network 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP2805 RNA interference 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP3924 Hfe effect on hepcidin production 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP2596 Gastric acid production 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP438 Non-homologous end joining 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP699 Aflatoxin B1 metabolism 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP528 Acetylcholine Synthesis 1.00000000000604 6.04183162517641e-12 7 0 0 22 5310 WP3850 Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling 1.00000000000624 6.24364508119192e-12 31 0 0 22 5310 WP2112 IL17 signaling pathway 1.00000000000624 6.24364508119192e-12 31 0 0 22 5310 WP2363 Gastric Cancer Network 2 1.00000000000628 6.28087643855576e-12 33 0 0 22 5310 WP453 Inflammatory Response Pathway 1.00000000000628 6.28087643855576e-12 33 0 0 22 5310 WP58 Monoamine GPCRs 1.00000000000628 6.28087643855576e-12 33 0 0 22 5310 WP24 Peptide GPCRs 1.00000000000636 6.3589871589909e-12 74 0 0 22 5310 WP2572 Primary Focal Segmental Glomerulosclerosis FSGS 1.00000000000636 6.3589871589909e-12 74 0 0 22 5310 WP1772 Apoptosis Modulation and Signaling 1.00000000000647 6.46527271234016e-12 94 0 0 22 5310 WP231 TNF alpha Signaling Pathway 1.00000000000647 6.46527271234016e-12 94 0 0 22 5310 WP2853 Endoderm Differentiation 1.0000000000068 6.80149256493581e-12 145 0 0 22 5310 WP111 Electron Transport Chain 1.0000000000069 6.89689328675474e-12 92 0 0 22 5310 WP712 Estrogen signaling pathway 1.00000000000697 6.97262609756671e-12 23 0 0 22 5310 WP3612 Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling 1.00000000000697 6.97262609756671e-12 23 0 0 22 5310 WP244 Alpha 6 Beta 4 signaling pathway 1.00000000000737 7.37309420963014e-12 35 0 0 22 5310 WP299 Nuclear Receptors in Lipid Metabolism and Toxicity 1.00000000000737 7.37309420963014e-12 35 0 0 22 5310 WP3617 Photodynamic therapy-induced NF-kB survival signaling 1.00000000000737 7.37309420963014e-12 35 0 0 22 5310 WP2446 Retinoblastoma (RB) in Cancer 1.00000000000763 7.6336655218678e-12 88 0 0 22 5310 WP1438 Influenza A virus infection 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2816 Felbamate Metabolism 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2646 Lidocaine metabolism 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2943 Hypoxia-mediated EMT and Stemness 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2366 Butyrate-induced histone acetylation 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP1311 Folic Acid Network 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP1273 Folic Acid Network 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2866 mir34a and TGIF2 in osteoclastogenesis 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP2901 Gonadotropin-releasing hormone (GnRH) signaling 1.00000000000834 8.34215621318339e-12 2 0 0 22 5310 WP1530 miRNA Regulation of DNA Damage Response 1.00000000000876 8.76047484993554e-12 93 0 0 22 5310 WP2355 Corticotropin-releasing hormone signaling pathway 1.00000000000876 8.76047484993554e-12 93 0 0 22 5310 WP3668 Hypothesized Pathways in Pathogenesis of Cardiovascular Disease 1.00000000000891 8.91241770018752e-12 25 0 0 22 5310 WP2895 Differentiation of white and brown adipocyte 1.00000000000891 8.91241770018752e-12 25 0 0 22 5310 WP205 IL-7 Signaling Pathway 1.00000000000891 8.91241770018752e-12 25 0 0 22 5310 WP2865 IL1 and megakaryocytes in obesity 1.00000000000891 8.91241770018752e-12 25 0 0 22 5310 WP1528 Physiological and Pathological Hypertrophy of the Heart 1.00000000000891 8.91241770018752e-12 25 0 0 22 5310 WP437 EGF/EGFR Signaling Pathway 1.00000000000917 9.17166081768109e-12 162 0 0 22 5310 WP3630 NAD metabolism, sirtuins and aging 1.00000000000924 9.23826073417091e-12 11 0 0 22 5310 WP80 Nucleotide GPCRs 1.00000000000924 9.23826073417091e-12 11 0 0 22 5310 WP1455 Serotonin Transporter Activity 1.00000000000924 9.23826073417091e-12 11 0 0 22 5310 WP2854 Gene regulatory network modelling somitogenesis 1.00000000000924 9.23826073417091e-12 11 0 0 22 5310 WP2513 Nanoparticle triggered regulated necrosis 1.00000000000924 9.23826073417091e-12 11 0 0 22 5310 WP1600 Nicotine Metabolism 1.00000000000963 9.62868192492899e-12 6 0 0 22 5310 WP694 Arylamine metabolism 1.00000000000963 9.62868192492899e-12 6 0 0 22 5310 WP3891 Benzene metabolism 1.00000000000963 9.62868192492899e-12 6 0 0 22 5310 WP1981 Thyroxine (Thyroid Hormone) Production 1.00000000000963 9.62868192492899e-12 6 0 0 22 5310 WP15 Selenium Micronutrient Network 1.00000000000966 9.65865496866801e-12 87 0 0 22 5310 WP1984 Integrated Breast Cancer Pathway 1.00000000000968 9.67758892526666e-12 154 0 0 22 5310 WP615 Senescence and Autophagy in Cancer 1.00000000000969 9.69251072944623e-12 106 0 0 22 5310 WP51 Regulation of Actin Cytoskeleton 1.00000000001003 1.00342396157336e-11 149 0 0 22 5310 WP45 G1 to S cell cycle control 1.00000000001013 1.01251558066404e-11 68 0 0 22 5310 WP3303 Rac1/Pak1/p38/MMP-2 pathway 1.00000000001013 1.01251558066404e-11 68 0 0 22 5310 WP410 Diurnally Regulated Genes with Circadian Orthologs 1.00000000001073 1.07304719537818e-11 49 0 0 22 5310 WP286 IL-3 Signaling Pathway 1.00000000001073 1.07304719537818e-11 49 0 0 22 5310 WP534 Glycolysis and Gluconeogenesis 1.00000000001073 1.07304719537818e-11 49 0 0 22 5310 WP2849 Hematopoietic Stem Cell Differentiation 1.00000000001132 1.13167532598536e-11 48 0 0 22 5310 WP2873 Aryl Hydrocarbon Receptor Pathway 1.00000000001132 1.13167532598536e-11 48 0 0 22 5310 WP2848 Differentiation Pathway 1.00000000001132 1.13167532598536e-11 48 0 0 22 5310 WP2586 Aryl Hydrocarbon Receptor 1.00000000001132 1.13167532598536e-11 48 0 0 22 5310 WP229 Irinotecan Pathway 1.00000000001164 1.16428652356816e-11 14 0 0 22 5310 WP322 Osteoblast Signaling 1.00000000001164 1.16428652356816e-11 14 0 0 22 5310 WP2436 Dopamine metabolism 1.00000000001164 1.16428652356816e-11 14 0 0 22 5310 WP12 Osteoclast Signaling 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP501 GPCRs, Class C Metabotropic glutamate, pheromone 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP550 Biogenic Amine Synthesis 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP1946 Cori Cycle 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP53 ID signaling pathway 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP2291 Deregulation of Rab and Rab Effector Genes in Bladder Cancer 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP2453 TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP3644 NAD+ metabolism 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310 WP47 Hedgehog Signaling Pathway 1.00000000001547 1.54732914828845e-11 16 0 0 22 5310